The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
Diverse Role of TGF-β in Kidney Disease
Open accessAbstract
Inflammation and fibrosis are two key pathological features of chronic kidney disease (CKD). Excessive renal inflammation leads to progressive renal fibrosis, which eventually results in the end-stage renal disease (ESRD). Transforming growth factor-β (TGF-β) has been considered as a master regulator that diversely regulates inflammation and fibrosis via both canonical and non-canonical signaling pathways. In the context of renal fibrosis, TGF-β1 is pathogenic. In contrast, TGF-β is also a potent anti-inflammatory cytokine that functions to regulate immune response on both immune cells and intrinsic kidney cells. Thus, generally blocking TGF-β signaling inhibits renal fibrosis but promotes renal inflammation. Mechanistically, TGF-β1 may activate its downstream signaling molecule Smad3 to transcriptionally and differentially regulate renal inflammation and fibrosis via Smad3-dependent non-coding RNAs, including miRNAs and l¬¬ncRNAs, which are negatively regulated by Smad7. All these findings underly the complexity of TGF-β1 in renal inflammation and fibrosis. Thus, treatment of renal fibrosis and inflammation by specifically targeting Smad3 and Smad3-dependent non-coding RNAs or by overexpressing Smad7 have been developed. In this review, the paradoxical functions and underlying mechanisms of TGF-β1 in diversely regulating renal inflammation and fibrosis are discussed and novel therapeutic strategies for kidney disease by targeting downstream TGF-β/Smad signaling and transcriptomes are highlighted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Zhang, Y., Huang, X.-R., Wei, L.-H., Chung, A. C., Yu, C.-M., & Lan, H.-Y. (2014) · Molecular Therapy · doi:10.1038/mt.2014.25 · Cited by 271
Self-citationRetractedChung, A. C. K., Dong, Y., Yang, W., Zhong, X., Li, R., & Lan, H. Y. (2012) · Molecular Therapy · doi:10.1038/mt.2012.251 · Cited by 152
Self-citationRetractedSmad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,373
TGF-β: the master regulator of fibrosis
Meng, X.-M., Nikolic-Paterson, D. J., & Lan, H. Y. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.48 · Cited by 3,528
Self-citationMassagué, J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3434 · Cited by 3,128
Kulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn, M. B., Ward, J. M., & Karlsson, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.770 · Cited by 1,967
Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling
Nakao, A., Afrakhte, M., Morn, A., Nakayama, T., Christian, J. L., Heuchel, R., Itoh, S., Kawabata, M., Heldin, N.-E., Heldin, C.-H., et al. (1997) · Nature · doi:10.1038/39369 · Cited by 1,809
Making sense of latent TGFβ activation
Annes, J. P., Munger, J. S., & Rifkin, D. B. (2003) · Journal of Cell Science · doi:10.1242/jcs.00229 · Cited by 1,628
Cellular and molecular mechanisms of renal fibrosis
Liu, Y. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.149 · Cited by 1,446
Hayashi, H., Abdollah, S., Qiu, Y., Cai, J., Xu, Y.-Y., Grinnell, B. W., Richardson, M. A., Topper, J. N., Gimbrone, M. A., Wrana, J. L., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80303-7 · Cited by 1,334
Gao, X., Wu, G., Gu, X., Fu, L., & Mei, C. (2013) · Kidney and Blood Pressure Research · doi:10.1159/000355743 · Cited by 1,035
Macrophages: versatile players in renal inflammation and fibrosis
Tang, P. M.-K., Nikolic-Paterson, D. J., & Lan, H.-Y. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0110-2 · Cited by 1,033
Self-citationRomagnani, P., Remuzzi, G., Glassock, R., Levin, A., Jager, K. J., Tonelli, M., Massy, Z., Wanner, C., & Anders, H.-J. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.88 · Cited by 996
Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1
Border, W. A., Okuda, S., Languino, L. R., Sporn, M. B., & Ruoslahti, E. (1990) · Nature · doi:10.1038/346371a0 · Cited by 988
Transcriptional and Post-Transcriptional Gene Regulation by Long Non-Coding RNA
Dykes, I. M., & Emanueli, C. (2017) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2016.12.005 · Cited by 914
Ziyadeh, F. N., Hoffman, B. B., Han, D. C., Iglesias-de la Cruz, M. C., Hong, S. W., Isono, M., Chen, S., McGowan, T. A., & Sharma, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120055097 · Cited by 907
TGF-β: A Master of All T Cell Trades
Li, M. O., & Flavell, R. A. (2008) · Cell · doi:10.1016/j.cell.2008.07.025 · Cited by 893
Ebisawa, T., Fukuchi, M., Murakami, G., Chiba, T., Tanaka, K., Imamura, T., & Miyazono, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100008200 · Cited by 844
Inflammatory processes in renal fibrosis
Meng, X.-M., Nikolic-Paterson, D. J., & Lan, H. Y. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.114 · Cited by 690
Self-citationInflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and Outcome
Mihai, S., Codrici, E., Popescu, I. D., Enciu, A.-M., Albulescu, L., Necula, L. G., Mambet, C., Anton, G., & Tanase, C. (2018) · Journal of Immunology Research · doi:10.1155/2018/2180373 · Cited by 673
Diverse Roles of TGF-β/Smads in Renal Fibrosis and Inflammation
Lan, H. Y. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.1056 · Cited by 652
Self-citationSignaling Cross Talk between TGF-β/Smad and Other Signaling Pathways
Luo, K. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022137 · Cited by 639
MicroRNA-21 Promotes Fibrosis of the Kidney by Silencing Metabolic Pathways
Chau, B. N., Xin, C., Hartner, J., Ren, S., Castano, A. P., Linn, G., Li, J., Tran, P. T., Kaimal, V., Huang, X., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003205 · Cited by 587
Self-citationSanz, A. B., Sanchez-Niño, M. D., Ramos, A. M., Moreno, J. A., Santamaria, B., Ruiz-Ortega, M., Egido, J., & Ortiz, A. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010020218 · Cited by 567
TGF-β/Smad3 Signaling Promotes Renal Fibrosis by Inhibiting miR-29
Qin, W., Chung, A. C. K., Huang, X. R., Meng, X.-M., Hui, D. S. C., Yu, C.-M., Sung, J. J. Y., & Lan, H. Y. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010121308 · Cited by 566
Self-citationThe miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury
Kriegel, A. J., Liu, Y., Fang, Y., Ding, X., & Liang, M. (2012) · Physiological Genomics · doi:10.1152/physiolgenomics.00141.2011 · Cited by 533
The global burden of chronic kidney disease: estimates, variability and pitfalls
Glassock, R. J., Warnock, D. G., & Delanaye, P. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.163 · Cited by 511
Suppression of microRNA-29 Expression by TGF-β1 Promotes Collagen Expression and Renal Fibrosis
Wang, B., Komers, R., Carew, R., Winbanks, C. E., Xu, B., Herman-Edelstein, M., Koh, P., Thomas, M., Jandeleit-Dahm, K., Gregorevic, P., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011010055 · Cited by 498
Fan, J.-M., Ng, Y.-Y., Hill, P. A., Nikolic-Paterson, D. J., Mu, W., Atkins, R. C., & Lan, H. Y. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00656.x · Cited by 471
Self-citationA mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA.
Bitzer, M., von Gersdorff, G., Liang, D., Dominguez-Rosales, A., Beg, A. A., Rojkind, M., & Böttinger, E. P. (2000) · PubMed · Cited by 461
Regulation of TGF-β Family Signaling by Inhibitory Smads
Miyazawa, K., & Miyazono, K. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022095 · Cited by 439
Regulation of TGF-β signaling by Smad7
Yan, X., Liu, Z., & Chen, Y. (2009) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmp018 · Cited by 436
Developmental signalling pathways in renal fibrosis: the roles of Notch, Wnt and Hedgehog
Edeling, M., Ragi, G., Huang, S., Pavenstädt, H., & Susztak, K. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.54 · Cited by 430
Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease.
Kopp, J. B., Factor, V. M., Mozes, M., Nagy, P., Sanderson, N., Böttinger, E. P., Klotman, P. E., & Thorgeirsson, S. S. (1996) · PubMed · Cited by 422
A mechanism of suppression of TGF–β/SMAD signaling by NF-κB/RelA
Bitzer, M., von Gersdorff, G., Liang, D., Dominguez-Rosales, A., Beg, A. A., Rojkind, M., & Böttinger, E. P. (2000) · Genes & Development · doi:10.1101/gad.14.2.187 · Cited by 421
Smad3-Mediated Upregulation of miR-21 Promotes Renal Fibrosis
Zhong, X., Chung, A. C. K., Chen, H.-Y., Meng, X.-M., & Lan, H. Y. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010111168 · Cited by 409
Self-citationChen, L., Yang, T., Lu, D.-W., Zhao, H., Feng, Y.-L., Chen, H., Chen, D.-Q., Vaziri, N. D., & Zhao, Y.-Y. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.090 · Cited by 359
miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes
Zhong, X., Chung, A. C. K., Chen, H. Y., Dong, Y., Meng, X. M., Li, R., Yang, W., Hou, F. F., & Lan, H. Y. (2013) · Diabetologia · doi:10.1007/s00125-012-2804-x · Cited by 355
Self-citationRole of the TGF-β/BMP-7/Smad pathways in renal diseases
Meng, X.-M., Chung, A. C. K., & Lan, H. Y. (2013) · Clinical Science · doi:10.1042/cs20120252 · Cited by 354
Self-citationmiR-192 Mediates TGF-β/Smad3-Driven Renal Fibrosis
Chung, A. C. K., Huang, X. R., Meng, X., & Lan, H. Y. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010020134 · Cited by 354
Self-citationTransforming growth factor‐β and Smad signalling in kidney diseases: Review Article
WANG, W., KOKA, V., & LAN, H. Y. (2005) · Nephrology · doi:10.1111/j.1440-1797.2005.00334.x · Cited by 347
Self-citationLan, H. Y., Mu, W., Tomita, N., Huang, X. R., Li, J. H., Zhu, H.-J., Morishita, R., & Johnson, R. J. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000067632.04658.b8 · Cited by 344
Self-citationSmad2 Protects against TGF-β/Smad3-Mediated Renal Fibrosis
Meng, X. M., Huang, X. R., Chung, A. C. K., Qin, W., Shao, X., Igarashi, P., Ju, W., Bottinger, E. P., & Lan, H. Y. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009121244 · Cited by 338
Self-citationMiyajima, A., Chen, J., Lawrence, C., Ledbetter, S., Soslow, R. A., Stern, J., Jha, S., Pigato, J., Lemer, M. L., Poppas, D. P., et al. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00414.x · Cited by 321
Pirfenidone for Diabetic Nephropathy
Sharma, K., Ix, J. H., Mathew, A. V., Cho, M., Pflueger, A., Dunn, S. R., Francos, B., Sharma, S., Falkner, B., McGowan, T. A., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010101049 · Cited by 319
Saharinen, J., Hyytiäinen, M., Taipale, J., & Keski-Oja, J. (1999) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(99)00010-6 · Cited by 315
Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis
Lancaster, L. H., de Andrade, J. A., Zibrak, J. D., Padilla, M. L., Albera, C., Nathan, S. D., Wijsenbeek, M. S., Stauffer, J. L., Kirchgaessler, K.-U., & Costabel, U. (2017) · European Respiratory Review · doi:10.1183/16000617.0057-2017 · Cited by 295
Macrophages promote renal fibrosis through direct and indirect mechanisms
Nikolic-Paterson, D. J., Wang, S., & Lan, H. Y. (2014) · Kidney International Supplements · doi:10.1038/kisup.2014.7 · Cited by 279
Self-citationRole of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects
López-Hernández, F. J., & López-Novoa, J. M. (2012) · Cell and Tissue Research · doi:10.1007/s00441-011-1275-6 · Cited by 276
Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy
Voelker, J., Berg, P. H., Sheetz, M., Duffin, K., Shen, T., Moser, B., Greene, T., Blumenthal, S. S., Rychlik, I., Yagil, Y., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015111230 · Cited by 275
TGF-β signaling in the kidney: profibrotic and protective effects
Sureshbabu, A., Muhsin, S. A., & Choi, M. E. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00365.2015 · Cited by 267
Trachtman, H., Fervenza, F. C., Gipson, D. S., Heering, P., Jayne, D. R. W., Peters, H., Rota, S., Remuzzi, G., Rump, L. C., Sellin, L. K., et al. (2011) · Kidney International · doi:10.1038/ki.2011.33 · Cited by 263
Yang, F., Chung, A. C. K., Huang, X. R., & Lan, H. Y. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.136531 · Cited by 258
Self-citationTargeting TGF-β Signaling in Kidney Fibrosis
Isaka, Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092532 · Cited by 252
Li, J., Qu, X., Yao, J., Caruana, G., Ricardo, S. D., Yamamoto, Y., Yamamoto, H., & Bertram, J. F. (2010) · Diabetes · doi:10.2337/db09-1631 · Cited by 250
Li, J. H., Zhu, H.-J., Huang, X. R., Lai, K. N., Johnson, R. J., & Lan, H. Y. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000014252.37680.e4 · Cited by 245
Self-citationMicroRNA-29c in urinary exosome/microvesicle as a biomarker of renal fibrosis
Lv, L.-L., Cao, Y.-H., Ni, H.-F., Xu, M., Liu, D., Liu, H., Chen, P.-S., & Liu, B.-C. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00148.2013 · Cited by 244
Identification of a microRNA signature in renal fibrosis: role of miR-21
Zarjou, A., Yang, S., Abraham, E., Agarwal, A., & Liu, G. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00273.2011 · Cited by 241
Signaling Mechanism of TGF-β1 in Prevention of Renal Inflammation: Role of Smad7
Wang, W., Huang, X. R., Li, A. G., Liu, F., Li, J.-H., Truong, L. D., Wang, X. J., & Lan, H. Y. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004121070 · Cited by 236
Self-citationmiR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7
McClelland, A. D., Herman-Edelstein, M., Komers, R., Jha, J. C., Winbanks, C. E., Hagiwara, S., Gregorevic, P., Kantharidis, P., & Cooper, M. E. (2015) · Clinical Science · doi:10.1042/cs20150427 · Cited by 235
Bone morphogenetic protein receptor signal transduction in human disease
Gomez‐Puerto, M. C., Iyengar, P. V., García de Vinuesa, A., ten Dijke, P., & Sanchez‐Duffhues, G. (2019) · The Journal of Pathology · doi:10.1002/path.5170 · Cited by 235
Essential Role of Smad3 in Angiotensin II–Induced Vascular Fibrosis
Wang, W., Huang, X. R., Canlas, E., Oka, K., Truong, L. D., Deng, C., Bhowmick, N. A., Ju, W., Bottinger, E. P., & Lan, H. Y. (2006) · Circulation Research · doi:10.1161/01.res.0000218782.52610.dc · Cited by 234
Self-citationHall, M.-C., Young, D. A., Waters, J. G., Rowan, A. D., Chantry, A., Edwards, D. R., & Clark, I. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212334200 · Cited by 232
TGF-β/Smad Signaling in Kidney Disease
Lan, H. Y., & Chung, A. C.-K. (2012) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.04.002 · Cited by 229
Self-citationThe Protective Role of Smad7 in Diabetic Kidney Disease: Mechanism and Therapeutic Potential
Chen, H. Y., Huang, X. R., Wang, W., Li, J. H., Heuchel, R. L., Chung, A. C. K., & Lan, H. Y. (2011) · Diabetes · doi:10.2337/db10-0403 · Cited by 225
Self-citationPirfenidone Slows Renal Function Decline in Patients with Focal Segmental Glomerulosclerosis
Cho, M. E., Smith, D. C., Branton, M. H., Penzak, S. R., & Kopp, J. B. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01050207 · Cited by 222
Smad7: not only a regulator, but also a cross-talk mediator of TGF-β signalling
Yan, X., & Chen, Y.-G. (2011) · Biochemical Journal · doi:10.1042/bj20101827 · Cited by 208
Increased Circulating miR-21 Levels Are Associated with Kidney Fibrosis
Glowacki, F., Savary, G., Gnemmi, V., Buob, D., Van der Hauwaert, C., Lo-Guidice, J.-M., Bouyé, S., Hazzan, M., Pottier, N., Perrais, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058014 · Cited by 205
Autoimmune manifestations in the transforming growth factor-beta 1 knockout mouse
Yaswen, L., Kulkarni, A., Fredrickson, T., Mittleman, B., Schiffman, R., Payne, S., Longenecker, G., Mozes, E., & Karlsson, S. (1996) · Blood · doi:10.1182/blood.v87.4.1439.bloodjournal8741439 · Cited by 204
Exosome-Mediated miR-29 Transfer Reduces Muscle Atrophy and Kidney Fibrosis in Mice
Wang, H., Wang, B., Zhang, A., Hassounah, F., Seow, Y., Wood, M., Ma, F., Klein, J. D., Price, S. R., & Wang, X. H. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.01.008 · Cited by 202
Chronic Kidney Disease Progression
Eddy, A. A., & Neilson, E. G. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006070704 · Cited by 200
Akagi, Y., Isaka, Y., Arai, M., Kaneko, T., Takenaka, M., Moriyama, T., Kaneda, Y., Ando, A., Orita, Y., Kamada, T., et al. (1996) · Kidney International · doi:10.1038/ki.1996.297 · Cited by 200
MicroRNA-29b Inhibits Diabetic Nephropathy in db/db Mice
Chen, H.-Y., Zhong, X., Huang, X. R., Meng, X.-M., You, Y., Chung, A. C., & Lan, H. Y. (2014) · Molecular Therapy · doi:10.1038/mt.2013.235 · Cited by 199
Self-citationMicroRNA-29 family, a crucial therapeutic target for fibrosis diseases
He, Y., Huang, C., Lin, X., & Li, J. (2013) · Biochimie · doi:10.1016/j.biochi.2013.03.010 · Cited by 193
Yan, X., Liao, H., Cheng, M., Shi, X., Lin, X., Feng, X.-H., & Chen, Y.-G. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.694281 · Cited by 191
Chung, A. C.-K., & Lan, H. Y. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00050 · Cited by 180
Self-citationAdvanced Glycation End-Products Induce Tubular CTGF via TGF-β–Independent Smad3 Signaling
Chung, A. C. K., Zhang, H., Kong, Y.-Z., Tan, J.-J., Huang, X. R., Kopp, J. B., & Lan, H. Y. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009010018 · Cited by 180
Self-citationMeng, X.-M., Huang, X. R., Xiao, J., Chung, A. C. K., Qin, W., Chen, H.-Y., & Lan, H. Y. (2012) · Kidney International · doi:10.1038/ki.2011.327 · Cited by 179
Self-citationKrϋppel-like factors (KLFs) in renal physiology and disease
Rane, M. J., Zhao, Y., & Cai, L. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.01.021 · Cited by 179
Wang, B., Jha, J. C., Hagiwara, S., McClelland, A. D., Jandeleit-Dahm, K., Thomas, M. C., Cooper, M. E., & Kantharidis, P. (2014) · Kidney International · doi:10.1038/ki.2013.372 · Cited by 175
Wang, P., Luo, M.-L., Song, E., Zhou, Z., Ma, T., Wang, J., Jia, N., Wang, G., Nie, S., Liu, Y., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aat2039 · Cited by 172
The microRNA miR-433 promotes renal fibrosis by amplifying the TGF-β/Smad3-Azin1 pathway
Li, R., Chung, A. C. K., Dong, Y., Yang, W., Zhong, X., & Lan, H. Y. (2013) · Kidney International · doi:10.1038/ki.2013.272 · Cited by 164
Self-citationSamarakoon, R., Dobberfuhl, A. D., Cooley, C., Overstreet, J. M., Patel, S. P., Goldschmeding, R., Meldrum, K. K., & Higgins, P. J. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.07.007 · Cited by 158
Hou, C., Wang, W., Huang, X. R., Fu, P., Chen, T.-H., Sheikh‐Hamad, D., & Lan, H. Y. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62297-3 · Cited by 158
Self-citationDeletion of Smad2 in Mouse Liver Reveals Novel Functions in Hepatocyte Growth and Differentiation
Ju, W., Ogawa, A., Heyer, J., Nierhof, D., Yu, L., Kucherlapati, R., Shafritz, D. A., & Böttinger, E. P. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.26.2.654-667.2006 · Cited by 157
TGF-β1/p53 signaling in renal fibrogenesis
Higgins, S. P., Tang, Y., Higgins, C. E., Mian, B. M., Zhang, W., Czekay, R., Samarakoon, R., Conti, D. J., & Higgins, P. J. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.11.005 · Cited by 156
Böttinger, E. P., Factor, V. M., Tsang, M., Weatherbee, J. A., Kopp, J. B., Qian, S. W., Wakefield, L. M., Roberts, A. B., Thorgeirsson, S. S., & Sporn, M. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5877 · Cited by 153
Vincenti, F. G., Fervenza, F. C., Campbell, K. N., Encarnación, M. M. D., Gesualdo, L., Nelson, P., Praga, M., Radhakrishnan, J., Sellin, L. K., Singh, A. K., et al. (2017) · Kidney International Reports · doi:10.1016/j.ekir.2017.03.011 · Cited by 153
Novel lncRNA Erbb4-IR Promotes Diabetic Kidney Injury in db/db Mice by Targeting miR-29b
Sun, S., Tang, P. M., Feng, M., Xiao, J., Huang, X. R., Li, P., Ronald, C. W., & Lan, H. Y. (2017) · Diabetes · doi:10.2337/db17-0816 · Cited by 152
Self-citationZhou, Q., Chung, A. C. K., Huang, X. R., Dong, Y., Yu, X., & Lan, H. Y. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.10.007 · Cited by 148
Self-citationDiverse roles of TGF‐β receptor II in renal fibrosis and inflammation in vivo and in vitro
Meng, X., Huang, X. R., Xiao, J., Chen, H., Zhong, X., Chung, A. C., & Lan, H. Y. (2011) · The Journal of Pathology · doi:10.1002/path.3976 · Cited by 148
Self-citationMicroRNA-21 in Glomerular Injury
Lai, J. Y., Luo, J., O'Connor, C. L., Jing, X., Nair, V., Ju, W., Randolph, A. E., Ben‐Dov, I. Z., Matar-Ujvary, R., Briskin, D., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013121274 · Cited by 145
TGF-β Mediates Renal Fibrosis via the Smad3-Erbb4-IR Long Noncoding RNA Axis
Feng, M., Tang, P. M., Huang, X., Sun, S., You, Y., Xiao, J., Lv, L., Xu, A., & Lan, H.-Y. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.09.024 · Cited by 142
Self-citationReversibility of established diabetic glomerulopathy by anti-TGF-β antibodies in db/db mice
Chen, S., de la Cruz, M. D. C. I., Jim, B., Hong, S. W., Isono, M., & Ziyadeh, F. N. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02708-0 · Cited by 137
Mechanism of chronic aristolochic acid nephropathy: role of Smad3
Zhou, L., Fu, P., Huang, X. R., Liu, F., Chung, A. C. K., Lai, K. N., & Lan, H. Y. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00675.2009 · Cited by 136
Self-citationmiR-200b Precursor Can Ameliorate Renal Tubulointerstitial Fibrosis
Oba, S., Kumano, S., Suzuki, E., Nishimatsu, H., Takahashi, M., Takamori, H., Kasuya, M., Ogawa, Y., Sato, K., Kimura, K., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013614 · Cited by 134
Long Noncoding RNA Arid2-IR Is a Novel Therapeutic Target for Renal Inflammation
Zhou, Q., Huang, X. R., Yu, J., Yu, X., & Lan, H. Y. (2015) · Molecular Therapy · doi:10.1038/mt.2015.31 · Cited by 127
Self-citationSmad7 Gene Therapy Ameliorates an Autoimmune Crescentic Glomerulonephritis in Mice
Ka, S., Huang, X., Lan, H.-Y., Tsai, P., Yang, S., Shui, H., & Chen, A. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080901 · Cited by 123
Self-citationTransforming growth factor‐β signalling in renal fibrosis: from Smads to non‐coding RNAs
Tang, P. M., Zhang, Y., Mak, T. S., Tang, P. C., Huang, X., & Lan, H. Y. (2018) · The Journal of Physiology · doi:10.1113/jp274492 · Cited by 123
Self-citationInflammatory Mediators and Renal Fibrosis
Meng, X. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-8871-2_18 · Cited by 123
Repression of transforming-growth-factor-β-mediated transcription by nuclear factor κB
Nagarajan, R. P., Feifei, C. H. E. N., Li, W., Vig, E., Harrington, M. A., Nakshatri, H., & Chen, Y. (2000) · Biochemical Journal · doi:10.1042/bj3480591 · Cited by 123
The epidermal growth factor receptor pathway in chronic kidney diseases
Harskamp, L. R., Gansevoort, R. T., van Goor, H., & Meijer, E. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.91 · Cited by 121
Latent TGF-β1 Protects Against Crescentic Glomerulonephritis
Huang, X. R., Chung, A. C. K., Zhou, L., Wang, X. J., & Lan, H. Y. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007040484 · Cited by 120
Self-citationKa, S., Yeh, Y.-C., Huang, X. R., Chao, T., Hung, Y.-J., Yu, C. P., Lin, T., Wu, C., Lan, H. Y., & Chen, A. W. (2011) · Diabetologia · doi:10.1007/s00125-011-2364-5 · Cited by 119
Self-citationSmad7 as a therapeutic agent for chronic kidney diseases
Lan, H. Y. (2008) · Frontiers in bioscience · doi:10.2741/3057 · Cited by 119
Self-citationRepression of transforming-growth-factor-beta-mediated transcription by nuclear factor kappaB.
Nagarajan, R. P., Chen, F., Li, W., Vig, E., Harrington, M. A., Nakshatri, H., & Chen, Y. (2000) · PubMed Central · Cited by 117
Ng, Y.-Y., Fan, J., Mu, W., Nikolic‐Paterson, D. J., Yang, W.-C., Huang, T., Atkins, R. C., & Lan, H. Y. (1999) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/14.12.2860 · Cited by 105
Self-citationRole of Smad4 on TGF-β–induced extracellular matrix stimulation in mesangial cells
Tsuchida, K., Zhu, Y., Siva, S., Dunn, S., & Sharma, K. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00009.x · Cited by 104
Meng, X., Zhang, Y., Huang, X., Ren, G., Li, J., & Lan, H. Y. (2015) · Oncotarget · doi:10.18632/oncotarget.6100 · Cited by 103
Self-citationSmad3 mediates ANG II-induced hypertensive kidney disease in mice
Liu, Z., Huang, X. R., & Lan, H. Y. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00595.2011 · Cited by 101
Self-citationLiu, G., Li, Y.-Q., Huang, X. R., Wei, L., Chen, H., Yong-jun, S., Heuchel, R. L., & Lan, H. Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053573 · Cited by 97
Self-citationMice overexpressing latent TGF-β1 are protected against renal fibrosis in obstructive kidney disease
Huang, X. R., Chung, A. C. K., Wang, X., Lai, K. N., & Lan, H. Y. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00021.2008 · Cited by 94
Self-citationBMP-7 as antagonist of organ fibrosis
Weiskirchen, R. (2009) · Frontiers in bioscience · doi:10.2741/3583 · Cited by 90
Long non-coding RNA-H19 antagonism protects against renal fibrosis
Xie, H., Xue, J., Feng, C. M., Jin, Y., & Fu, Q. (2016) · Oncotarget · doi:10.18632/oncotarget.10444 · Cited by 89
Du, N., Xu, Z., Gao, M., Liu, P., Sun, B., & Cao, X. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s171286 · Cited by 85
Unraveling Cardiovascular Risk in Renal Patients: A New Take on Old Tale
Provenzano, M., Coppolino, G., Nicola, L. D., Serra, R., Garofalo, C., Andreucci, M., & Bolignano, D. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00314 · Cited by 85
Transforming Growth Factor-β1/Smad7 in Intestinal Immunity, Inflammation, and Cancer
Troncone, E., Marafini, I., Stolfi, C., & Monteleone, G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01407 · Cited by 82
Zhang, Y., Tang, P. M., Tang, P. C., Xiao, J., Huang, X., Yu, C., Ronald, C. W., & Lan, H. Y. (2019) · Diabetes · doi:10.2337/db18-1075 · Cited by 81
Self-citationWang, Z., Han, Z., Tao, J., Wang, J., Liu, X., Zhou, W., Xu, Z., Zhao, C., Wang, Z., Tan, R., et al. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13157 · Cited by 80
Self-citationMuñoz‐Félix, J. M., González-Núñez, M., Martínez‐Salgado, C., & López-Novoa, J. M. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.10.003 · Cited by 78
Opposing Roles for Smad2 and Smad3 in Peritoneal Fibrosis in Vivo and in Vitro
Duan, W., Yu, X., Huang, X., Yu, J., & Lan, H. Y. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.04.014 · Cited by 71
Self-citationZhou, Y., Xiong, M., Fang, L., Jiang, L., Wen, P., Dai, C., Zhang, C., & Yang, J. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.06.032 · Cited by 70
MicroRNA and nephropathy: emerging concepts
Lan, H. Y., Chung, A. C. K., & Yu, X. (2013) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s37885 · Cited by 69
Self-citationMicroRNA-29b inhibits peritoneal fibrosis in a mouse model of peritoneal dialysis
Yu, J., Duan, W., Huang, X., Meng, X., Yu, X., & Lan, H.-Y. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2014.91 · Cited by 63
Self-citationTherapeutic Effects of Tangshen Formula on Diabetic Nephropathy in Rats
Zhao, T., Sun, S., Zhang, H., Huang, X., Yan, M., Dong, X., Wen, Y., Wang, H., Lan, H. Y., & Li, P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147693 · Cited by 63
Self-citationChong, P. A., Lin, H., Wrana, J. L., & Forman-Kay, J. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601493200 · Cited by 59
The preventive and therapeutic implication for renal fibrosis by targetting TGF-β/Smad3 signaling
Zhang, Y., Meng, X., Huang, X., & Lan, H. Y. (2018) · Clinical Science · doi:10.1042/cs20180243 · Cited by 59
Self-citationLu, X., Zou, W., Yaqian, D., Zhou, D., Xueli, T., Dong, Z., Guanyi, L., Tang, L. Y., & Menghua, L. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.09.009 · Cited by 59
Ando, T., Okuda, S., Tamaki, K., Yoshitomi, K., & FUJISHIMA, M. (1995) · Kidney International · doi:10.1038/ki.1995.112 · Cited by 58
Smad7 inhibits AngII-mediated hypertensive nephropathy in a mouse model of hypertension
Liu, G., Li, Y.-Q., Huang, X. R., Li, W., Zhang, Y., Feng, M., Meng, X., Chen, H., Yong-jun, S., & Lan, H. Y. (2014) · Clinical Science · doi:10.1042/cs20130706 · Cited by 53
Self-citationThe Changing Landscape of Renal Inflammation
Ernandez, T., & Mayadas, T. N. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.12.002 · Cited by 51
Loeffler, I., Liebisch, M., Allert, S., Kunisch, E., Kinne, R. W., & Wolf, G. (2017) · Cell and Tissue Research · doi:10.1007/s00441-017-2754-1 · Cited by 51
siRNAs targeted to Smad4 prevent renal fibrosis in vivo
Morishita, Y., Yoshizawa, H., Watanabe, M., Ishibashi, K., Muto, S., Kusano, E., & Nagata, D. (2014) · Scientific Reports · doi:10.1038/srep06424 · Cited by 47
Loss of Smad7 Promotes Inflammation in Rheumatoid Arthritis
Zhou, G., Sun, X., Qin, Q., Lv, J., Cai, Y., Wang, M., Mu, R., Lan, H.-Y., & Wang, Q. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02537 · Cited by 42
Self-citationQiu, J., Chen, Y., Huang, G., Zhang, Z., Chen, L., & Na, N. (2016) · Nephrology · doi:10.1111/nep.12851 · Cited by 41
Long non-coding RNAs: An essential emerging field in kidney pathogenesis
Sani, H. M., Hejazian, S. M., Khatibi, S. M. H., Ardalan, M., & Vahed, S. Z. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.01.122 · Cited by 39
Xiao, X., Yuan, Q., Chen, Y., Huang, Z., Fang, X., Zhang, H., Peng, L., & Xiao, P. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27590 · Cited by 39
Transcriptome Identified lncRNAs Associated with Renal Fibrosis in UUO Rat Model
Sun, J., Zhang, S., Shi, B., Zheng, D., & Shi, J. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00658 · Cited by 38
Kusakabe, M., Cheong, P. L., Nikfar, R., McLennan, I. S., & Koishi, K. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21407 · Cited by 35
The Smad3/Smad4/CDK9 complex promotes renal fibrosis in mice with unilateral ureteral obstruction
Qu, X., Jiang, M., Sun, Y., Jiang, X., Fu, P., Ren, Y., Wang, D., Dai, L., Caruana, G., Bertram, J. F., et al. (2015) · Kidney International · doi:10.1038/ki.2015.235 · Cited by 30
Meeting report – TGF-β superfamily: signaling in development and disease
Zhang, Y. E., & Newfeld, S. J. (2013) · Journal of Cell Science · doi:10.1242/jcs.142398 · Cited by 23
microRNA and Kidney Transplantation
Jelencsics, K. E., & Oberbauer, R. W. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-22671-2_14 · Cited by 12
Preparation and evaluation of anti‐renal fibrosis activity of novel truncated TGF‐β receptor type II
Liu, H., Zhang, Z., Li, Y., Wang, X., Zhang, Y., Chu, Y., Yuan, X., & Wang, X. (2018) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.1667 · Cited by 8
Metadata
- Authors
- Gu, Y.-Y., Liu, X.-S., Huang, X.-R., Yu, X.-Q., & Lan, H.-Y.
- Venue
- Frontiers in Cell and Developmental Biology
- Publisher
- Frontiers Media SA
- Published
- 2020-02-28
- Volume
- 8
- Pages
- 123-123
- ISSN
- 2296-634X (ISSN-L)
- OpenAlex
- W3008074101
- Cited by
- 257
- References
- 143
- FWCI
- 8.85
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.